Within the glycolysis pathway, genes such as HK2, PFKP, and PKM displayed elevated expression, thereby emerging as prospective targets warranting exploration for restraining tumor cell glycolytic activity (Fig. 2B and Additional file 2: Fig. S2B–D). This evidence concerns the gene HK2 and neoplasm.